Cargando…

Corrigendum: Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity

Detalles Bibliográficos
Autores principales:	La Manna, Federico, De Menna, Marta, Patel, Nikhil, Karkampouna, Sofia, De Filippo, Maria Rosaria, Klima, Irena, Kloen, Peter, Beimers, Lijkele, Thalmann, George N., Pelger, Rob C. M., Jacinto, Estela, Kruithof-de Julio, Marianna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887433/ https://www.ncbi.nlm.nih.gov/pubmed/33614519 http://dx.doi.org/10.3389/fonc.2021.650623

Ejemplares similares

Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity
por: La Manna, Federico, et al.
Publicado: (2020)

mTOR Inhibitor Rapalink-1 Prevents Ethanol-Induced Senescence in Endothelial Cells
por: Zhou, Huakang, et al.
Publicado: (2023)

Stroma Transcriptomic and Proteomic Profile of Prostate Cancer Metastasis Xenograft Models Reveals Prognostic Value of Stroma Signatures
por: Karkampouna, Sofia, et al.
Publicado: (2020)

Rapalink-1 Increased Infarct Size in Early Cerebral Ischemia–Reperfusion With Increased Blood–Brain Barrier Disruption
por: Chi, Oak Z., et al.
Publicado: (2021)

The Role of Cancer-Associated Fibroblasts in Prostate Cancer Tumorigenesis
por: Bonollo, Francesco, et al.
Publicado: (2020)

Patient-derived xenografts and organoids model therapy response in prostate cancer
por: Karkampouna, Sofia, et al.
Publicado: (2021)

A Multidisciplinary Review of the Roles of Cripto in the Scientific Literature Through a Bibliometric Analysis of its Biological Roles
por: Rodrigues Sousa, Elisa, et al.
Publicado: (2020)

CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer
por: Zoni, E, et al.
Publicado: (2017)

Targeting mTOR and Metabolism in Cancer: Lessons and Innovations
por: Magaway, Cedric, et al.
Publicado: (2019)

An ex vivo Tissue Culture Model for the Assessment of Individualized Drug Responses in Prostate and Bladder Cancer
por: van de Merbel, Arjanneke F., et al.
Publicado: (2018)

A 3-portal approach for arthroscopic subtalar arthrodesis
por: Beimers, Lijkele, et al.
Publicado: (2009)

Connective Tissue Degeneration: Mechanisms of Palmar Fascia Degeneration (Dupuytren’s Disease)
por: Karkampouna, S., et al.
Publicado: (2016)

Bladder cancer organoids as a functional system to model different disease stages and therapy response
por: Minoli, Martina, et al.
Publicado: (2023)

ALK1Fc Suppresses the Human Prostate Cancer Growth in in Vitro and in Vivo Preclinical Models
por: Astrologo, Letizia, et al.
Publicado: (2017)

Manipulation under anaesthesia for frozen shoulders: outdated technique or well-established quick fix?
por: Kraal, Tim, et al.
Publicado: (2019)

Corticosteroid injection alone vs additional physiotherapy treatment in early stage frozen shoulders
por: Kraal, Tim, et al.
Publicado: (2018)

Prediction of Biochemical Recurrence Based on Molecular Detection of Lymph Node Metastasis After Radical Prostatectomy
por: Özdemir, Berna C., et al.
Publicado: (2022)

Rapalink-1 Targets Glioblastoma Stem Cells and Acts Synergistically with Tumor Treating Fields to Reduce Resistance against Temozolomide
por: Vargas-Toscano, Andres, et al.
Publicado: (2020)

Commentary: Rapalink-1 Increased Infarct Size in Early Cerebral Ischemia–Reperfusion With Increased Blood–Brain Barrier Disruption
por: Beard, Daniel J., et al.
Publicado: (2021)

Biological Aspects of mTOR in Leukemia
por: Mirabilii, Simone, et al.
Publicado: (2018)

mTOR Regulation of Metabolism in Hematologic Malignancies
por: Mirabilii, Simone, et al.
Publicado: (2020)

Prolonging hormone sensitivity in prostate cancer xenografts through dual inhibition of AR and mTOR
por: Schayowitz, A, et al.
Publicado: (2010)

IGF and mTOR pathway expression and in vitro effects of linsitinib and mTOR inhibitors in adrenocortical cancer
por: De Martino, Maria Cristina, et al.
Publicado: (2019)

MTOR Signaling and Metabolism in Early T Cell Development
por: Werlen, Guy, et al.
Publicado: (2021)

Overcoming mTOR Resistance Mutations with a New Generation mTOR Inhibitor
por: Rodrik-Outmezguine, Vanessa S., et al.
Publicado: (2016)

Novel Ex Vivo Culture Method for the Study of Dupuytren's Disease: Effects of TGFβ Type 1 Receptor Modulation by Antisense Oligonucleotides
por: Karkampouna, Sofia, et al.
Publicado: (2014)

In Silico Strategy for Targeting the mTOR Kinase at Rapamycin Binding Site by Small Molecules
por: Vittorio, Serena, et al.
Publicado: (2021)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

Measuring hindfoot alignment radiographically: the long axial view is more reliable than the hindfoot alignment view
por: Reilingh, Mikel L., et al.
Publicado: (2010)

Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications
por: Minoli, Martina, et al.
Publicado: (2020)

Chronic modulation of AMP-Kinase, Akt and mTOR pathways by ionizing radiation in human lung cancer xenografts
por: Storozhuk, Yaryna, et al.
Publicado: (2012)

Dual mTOR inhibitor MLN0128 suppresses Merkel cell carcinoma (MCC) xenograft tumor growth
por: Kannan, Aarthi, et al.
Publicado: (2015)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

Potential new therapy of Rapalink‐1, a new generation mammalian target of rapamycin inhibitor, against sunitinib‐resistant renal cell carcinoma
por: Kuroshima, Kazuki, et al.
Publicado: (2020)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo
por: Kiener, Mirjam, et al.
Publicado: (2019)

Oncofetal Protein CRIPTO Is Involved in Wound Healing and Fibrogenesis in the Regenerating Liver and Is Associated with the Initial Stages of Cardiac Fibrosis
por: Karkampouna, Sofia, et al.
Publicado: (2021)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_40sho5tngr0t9233oeabo0tcgi